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List of abbreviations used 
AHA, American Heart Association; ARS, Axenfeld-Rieger syndrome; CFL1, cofilin 1; ChIP, 
chromatin immunoprecipitation; CKO, conditional knock out; CNC, cranial neural crest; 
CVH, cerebellar vermis hypoplasia; DAPI, diamidino-2-phenylindole; dUTP, 
deoxynucleotidyl transferase; DWM, Dandy-Walker malformation; FACS, fluorescence-
activated cell sorting; Fox, forkhead box; GFP, green fluorescent protein; H&E, hematoxylin 
and eosin; NC, neural crest; OPT, optical projection tomography; PBS, phosphate buffered 
saline; Pdgfb, Platelet-derived growth factor b; PFA, paraformaldehyde; pYAP, 
phosphorylated Yap; RNA-Seq, RNA-sequencing; SDG, Scientist Development Grant; 
SFRP, secreted Frizzled-related protein; SMA, smooth muscle actin; TEA, transcriptional 
enhancer activator; Tead, TEA domain; TUNEL, terminal deoxynucleotidyl transferase nick 
end labeling. 
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ABSTRACT 
The role of the Hippo signaling pathway in cranial neural crest (CNC) development is poorly 
understood. We used the Wnt1Cre and Wnt1Cre2SOR drivers to conditionally ablate both Yap and 
Taz in the CNC of mice. When using either Cre driver, Yap and Taz deficiency in the CNC 
resulted in enlarged, hemorrhaging branchial arch blood vessels and hydrocephalus. 
However, Wnt1Cre2SOR embryos had an open cranial neural tube phenotype that was not 
evident in Wnt1Cre embryos. In O9-1 CNC cells, the loss of Yap and Taz impaired smooth 
muscle cell differentiation. RNA-sequencing data indicated that Yap and Taz regulate genes 
encoding Fox transcription factors, specifically Foxc1. Proliferation was reduced in the 
branchial arch mesenchyme of Yap and Taz CNC conditional knockout (CKO) embryos. 
Moreover, Yap and Taz CKO embryos had cerebellar aplasia similar to Dandy Walker 
spectrum malformations observed in human patients and mouse embryos with mutations in 
Foxc1. In embryos and O9-1 cells deficient for Yap and Taz, Foxc1 expression was 
significantly reduced. Analysis of Foxc1 regulatory regions revealed a conserved recognition 
element for the Yap and Taz DNA binding co-factor Tead. ChIP-pcr experiments further 
supported the conclusion that Foxc1 is directly regulated by the Yap/Tead complex. Our 
findings uncover important roles for Yap and Taz in CNC diversification and development.  
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INTRODUCTION 
The neural crest (NC) is a migratory, multipotent cell population that originates in the 
embryonic dorsal neural tube. Developmental defects in NC formation result in numerous 
human congenital anomalies. Based on the site of origin, NC cells are divided into cranial, 
cardiac, and trunk populations, each of which has its own unique developmental potential. 
The cranial neural crest (CNC) ultimately diversifies into multiple cells types including 
neuronal, glial, cartilage, bone, and smooth muscle cells (Santagati and Rijli, 2003). 
Mutations in the genes required for CNC development are often associated with the 
pathophysiology of human congenital malformations (Acloque et al., 2009; Cordero et al., 
2011), highlighting the clinical importance of understanding the molecular mechanisms 
governing CNC development.  Much effort has been expended interrogating the gene 
regulatory networks underlying NC development (Sauka-Spengler and Bronner-Fraser, 
2008). Major signaling pathways, including Wnt, Fgf, Bmp, and Notch signaling, have been 
shown to play important roles in regulating NC induction, proliferation, and migration (Sela-
Donenfeld and Kalcheim, 1999; Garcia-Castro et al., 2002; Coles et al., 2004; Glavic et al., 
2004; Carmona-Fontaine et al., 2008). However, the function of Hippo signaling in CNC 
development remains poorly understood. 
Hippo signaling is a critical pathway that regulates organ size through the modulation 
of cell proliferation (Heallen et al., 2011). The key components of the Hippo signaling 
pathway are evolutionarily conserved. In mice, Mst1/2 (orthologous to Drosophila 
melanogaster Hpo) and Salv (orthologous to human WW45) form a complex that 
phosphorylates the kinases Lats 1/2 (orthologous to Drosophila Warts). Lats 1/2, in turn, 
phosphorylate the most downstream Hippo signaling components Yap and Taz, thus 
promoting their binding to 14-3-3 proteins and inhibiting them from shuttling into the 
nucleus. In the absence of Hippo signaling repressive activity, Yap and Taz localize in the 
nucleus and partner with transcription factors, such as transcriptional enhancer activator 
(TEA) domain (Tead) family members, to promote gene programs favoring proliferation. 
Recently, familial studies have shown that heterozygous nonsense mutations in YAP1 are 
associated with variable phenotypes in the affected families, including orofacial clefting and 
intellectual disability (Williamson et al., 2014). However, the mechanisms underlying these 
phenotypic alterations remain unclear. 
In this study, we investigated Yap and Taz function in the CNC. Using two Wnt1 Cre 
drivers, we uncover important functions Yap and Taz CNC proliferation and subsequent CNC 
differentiation. 
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RESULTS 
Yap and Taz deletion in CNC-derived cells results in embryonic lethality 
To determine the function of Yap and Taz in the CNC, we generated compound Yap and Taz 
conditional mutants by using conditional null alleles and the CNC Wnt1Cre and Wnt1Cre2SOR 
drivers. We collected embryos at multiple developmental stages to analyze the 
morphogenesis of several CNC-derived structures. Importantly, the Wnt1Cre driver (Chai et 
al., 2000) has been shown to induce ectopic expression of Wnt1, leading to defects in 
midbrain development, whereas the Wnt1Cre2SOR driver does not have these issues (Lewis et 
al., 2013). 
We first evaluated embryos in which Yap and Taz were deleted using the Wnt1Cre 
driver. In control embryos, phosphorylated Yap (pYAP)—a readout for Hippo signaling 
activity—was present in CNC-derived cells, such as mandibular mesenchymal cells (Fig. 
1A,B). However, in Wnt1Cre; Yap; Taz double conditional knockout (dCKO) embryos, the 
level of pYAP was dramatically reduced in CNC-derived cells, but unchanged in non–CNC-
derived cells such as endothelium (Fig. 1C,D). These data indicated that the Wnt1Cre driver 
efficiently inactivated Yap and Taz in CNC-derived cells. Among the different mutant 
genotypes, both Wnt1Cre; Yapf/f; Tazf/+ and Wnt1Cre; Yap; Taz dCKO were embryonic lethal at 
embryonic day 10.5 (E10.5) (Table S1). Mutant embryos with the reciprocal genotype of 
Wnt1Cre; Yapf/+; Tazf/f displayed lethality over a wide range of developmental time points, 
from E14.5 to postnatal week 8 (Table S1). 
In addition, we used the Wnt1Cre2SOR driver (Lewis et al., 2013) to inactivate Yap and 
Taz in CNC. Similar to Wnt1Cre embryos, lethality was observed at E10.5 in both Wnt1Cre2SOR; 
Yapf/f; Tazf/+ and Wnt1Cre2SOR; Yap; Taz dCKO embryos, whereas Wnt1Cre2SOR; Yapf/+; Tazf/f 
embryos survived until E15.5, the latest developmental stage examined in this study (Table 
S2). Together, our findings indicate that embryos with Yap and Taz compound loss of 
function or Yap deletion with Taz haploinsufficiency in the CNC exhibit early embryonic 
lethality, whereas embryos with Taz deletion and Yap haploinsufficiency in the CNC survive 
until later developmental stages. 
 
Yap and Taz deletion in Wnt1Cre and Wnt1Cre2SOR embryos results in similar vascular 
defects, but distinct neural tube phenotypes 
No obvious craniofacial morphologic defects were observed in Yap and Taz compound 
mutants at E9.5. At E10.5, neither control embryos, including Yap and Taz compound 
heterozygous embryos and embryos without Wnt1Cre (Fig. S1A-C), nor Wnt1Cre; Yapf/+; Tazf/f 
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embryos (Fig. S1D-F) displayed any obvious craniofacial defects.  The Wnt1Cre; Yapf/f; Tazf/+ 
(Fig. S1G-I) and Wnt1Cre; Yap; Taz dCKO (Fig. S1J-L,P-R) embryos survived until E10.5 and 
showed disrupted craniofacial structures, including enlarged blood vessels in the branchial 
arch and hemorrhage in the forebrain and mandible at E10.5. 
Similar to Wnt1Cre; Yap; Taz mutant embryos, E10.5, lethality was observed in 
Wnt1Cre2SOR; Yap; Taz dCKO (Fig. 2A-D) and Wnt1Cre2SOR; Yapf/f; Tazf/+ (Fig. 2M-P) embryos. 
The E10.5 mutant embryos exhibited disrupted craniofacial structures, including blood vessel 
enlargement and hemorrhage, which are phenotypes we observed in Wnt1Cre compound 
mutant embryos. These early CNC phenotypes were not observed in Wnt1Cre2SOR; Yapf/+; 
Tazf/f embryos that have one functional copy of Yap or controls (Fig. 2E-L). Wnt1Cre2SOR 
compound mutant embryos lacked any obvious morphologic defects at E9.5. Notably, both 
E10.5 Wnt1Cre2SOR; Yapf/f; Tazf/+ (Fig. 2P,p) and Wnt1Cre2SOR; Yap; Taz dCKO (Fig. 2D,R) 
embryos had neural tube defects, which is one of the most common human birth defects. At 
E10.5, all (14/14) Wnt1Cre2SOR; Yap; Taz dCKO embryos displayed open anterior neural tubes 
(Fig. 2D,R), and most (7/11) Wnt1Cre2SOR; Yapf/f; Tazf/+ embryos presented with less severe, 
but still abnormal, anterior neural tube morphology (Fig. 2P,p). Neural tube defects were not 
observed in any of the Yap; Taz compound mutant embryos generated using Wnt1Cre (Fig. 
S1). 
Histologic analysis indicated that, compared to control embryos (Fig. 3A-D; Fig. 
S2A-C), both Wnt1Cre; Yap; Taz dCKO (Fig. 3E-L; Fig. S2D-F) and Wnt1Cre; Yapf/f; Tazf/+ 
(Fig. 3M-P; Fig. S2 G-I) embryos had enlarged blood vessels. Moreover, the mandibular 
mesenchyme was disorganized in Wnt1Cre; Yap; Taz dCKO (Fig. 3G,H) and Wnt1Cre; Yapf/f; 
Tazf/+ (Fig. 3O,P) embryos. The sparse mesenchyme in the mandible suggests that there are 
fewer pericytes to be recruited from the surrounding mesenchyme due to lack of in Yap and 
Taz in CNC-derived tissues, thus deficient support from the blood vessels surrounding cells 
likely caused hemorrhage in mutants.  
 
Yap and Taz deletion causes severe neural tube vessel regression 
To more closely examine the hemangioma phenotype in the forebrain, branchial arch, and 
mandibular regions in Wnt1Cre; Yap; Taz dCKO embryos, we performed whole mount 
immunofluorescence staining for CD31 (Pecam1, endothelial cell marker) and smooth 
muscle actin (SMA, a smooth muscle cell marker), followed by imaging with Lightsheet 
microscopy. In contrast to control embryos (Fig. 4A), the hemangiomas present in the 
branchial arch of Wnt1Cre; Yap; Taz dCKO embryos are encapsulated by CD31-positive 
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endothelium (Fig. 4B). In addition, the results of three-dimensional rendering and maximum 
intensity projection of the branchial arch in a Yap; Taz dCKO embryo further supported that 
the vessels were wrapped around the hemangioma in the branchial arch of the Yap; Taz 
dCKO embryo (Fig. 4C). Similar endothelial-lined hemangiomas were also identified in the 
forebrain and mandibular regions in other dCKO embryos. Images of CD31 immunostaining 
also revealed abnormal vessel regression throughout the brain of Wnt1Cre; Yap; Taz dCKO 
embryos. By comparing control embryos (Fig. 4D-F) with Wnt1Cre; Yapf/f; Tazf/f embryos 
(Fig. 4G-I), we detected several regions where vessel regression and/or disorganization was 
present in Wnt1Cre; Yapf/f; Tazf/f embryos (regions labeled as 1-4 in Fig. 4G-I), demonstrating 
that Yap and Taz within the CNC is required for normal vascularization of the early brain and 
mandibular region. 
 
RNA-sequencing reveals genes regulated by the Hippo pathway in the CNC 
Because the mandibular phenotype in Yap; Taz dCKO embryos appeared to be consistent in 
both CNC-specific Cre lines, we focused our attention on the molecular mechanism 
underlying the enlarged cranial and facial vessels. We performed RNA-sequencing (RNA-
Seq) analysis by using mandibular RNA isolated from E10.5 Wnt1Cre; Yap; Taz dCKO and 
control embryos. RNA-Seq analysis of the mandibular tissue from Wnt1Cre; Yap; Taz dCKO 
embryos revealed efficient ablation of Yap and Taz (Fig. 5A). Among the differentially 
expressed genes, 355 were upregulated and 77 were downregulated (Fig. S3A). We noted that 
a large percentage of the differentially expressed genes (11%) were DNA binding factors 
(Fig. S3B). 
Gene ontology analysis indicated that genes upregulated in Wnt1Cre; Yap; Taz dCKO 
embryos are involved in regulating adherens junction formation, vasoconstriction, 
cytoskeleton, and positive regulation of endothelial cell migration (Fig. 5B). Genes 
downregulated in Wnt1Cre; Yap; Taz dCKO embryos primarily function in cell proliferation, 
extracellular matrix organization, and vasculogenesis (Fig. 5C). 
Among the downregulated genes, we identified those that negatively regulate the 
canonical Wnt signaling pathway, including the secreted Frizzled-related protein (SFRP) 
Sfrp2, a Wnt inhibitor that directly binds Wnt ligands (Ladher et al., 2000). Notably, Wnt1Cre; 
Yap; Taz dCKO embryos had reduced Foxc1 expression (Fig. 5D). Foxc1 has been 
implicated in ocular and cerebellar malformations in human patients, as well as in vascular 
malformations in mice (Kume et al., 2001; Kume, 2009; Delahaye et al., 2012; Haldipur et 
al., 2014). 
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Among the transcripts upregulated in Wnt1Cre Yap; Taz dCKO embryos, we identified 
genes encoding components of the Jak-Stat cascade, including Jak3, Ptk2b, Stat3, Stat5a, and 
Stat5b (Fig. 5D). Interestingly, Jak-Stat signaling controls organ size in Drosophila, much 
like the Hippo pathway. In vertebrates, the Jak-Stat pathway is involved in growth hormone 
signaling, although it is less clear what the predicted consequence of increased Jak-Stat levels 
would be during development. We also found that Prospero Homeobox Protein 1 (Prox1) 
expression is upregulated in Wnt1Cre; Yap; Taz dCKO embryos. Prox1 encodes a transcription 
factor that is a master regulator of lymphatic endothelial cell specification and identity, and is 
essential for normal vascular development (Wigle and Oliver, 1999; Wigle et al., 2002; 
Johnson et al., 2008). Another upregulated vascular mitogen was Platelet-derived growth 
factor b (Pdgfb), which promotes the recruitment and proliferation of vascular cells 
(Yancopoulos et al., 2000). Pdgfb deficiency leads to reduced numbers of microvascular-
associated pericytes in mouse embryos (Lindahl et al., 1997). Wnt1Cre; Yap; Taz dCKO 
embryos also had upregulated expression of Forkhead Box E1 (Foxe1), which has been 
implicated as a causative gene in human orofacial clefting (Moreno et al., 2009). 
 
Yap and Taz regulate proliferation and apoptosis in the CNC 
As indicated by our RNA-Seq data analysis (Fig. 5C), cell proliferation genes were 
downregulated in Wnt1Cre; Yap; Taz dCKO embryos compared to control embryos. To 
evaluate differences in proliferation in vivo, we performed phospho-histone H3 (pHH3) 
immunofluorescence staining on sections from both E9.5 and E10.5 Yap; Taz dCKO and 
control embryos. The percentage of proliferating, pHH3-positive cells was lower in the 
mandible of Wnt1Cre; Yap; Taz dCKO embryos (E9.5 Fig. 6C,D; E10.5 Fig. 6H,I) than in that 
of control embryos (E9.5 Fig. 6A,B; E10.5 Fig. 6F,G). Furthermore, quantification of pHH3-
positive cells indicated that the rate of proliferation was significantly lower in Wnt1Cre; Yap; 
Taz dCKO embryos than in control embryos at both E9.5 and E10.5 (Fig. 6E,J). 
To further evaluate the role of the Hippo pathway in CNC cells, we used the O9-1 cell 
line for in vitro analyses. The O9-1 cell line is a stable, multipotent, mesenchymal CNC cell 
line, originally derived from Wnt1Cre; R26R-green fluorescent protein (GFP)-expressing cells 
and can differentiate into multiple CNC-derivatives, including osteoblasts, chondrocytes, 
smooth muscle cells, and glial cells (Ishii et al., 2012). To examine cell proliferation in 
response to altered Hippo signaling, we used siRNA-mediated knockdown to reduce Yap and 
Taz, as well as Lats1 and Lats2, levels in O9-1 cells, and performed pHH3 
immunofluorescence staining to assess cell proliferation. The percentage of pHH3-positive 
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cells was decreased in cells treated with siRNA against Yap and Taz (Fig. 6L), but was 
increased in cells treated with siRNAs targeting Lats1 and Lats2 (Fig. 6M) compared to cells 
treated with control siRNA (Fig. 6K). Based on cell counting, the proliferation rate was 
significantly reduced in Yap and Taz knockdown cells but significantly increased in Lats1 
and Lats2 knockdown cells when compared with control siRNA-treated cells (Fig. 6N). 
Although cell proliferation was reduced in the mandible of Wnt1Cre; Yap; Taz dCKO 
embryos, these mutant embryos showed no obvious defects in neural tube morphogenesis. 
We also evaluated cell proliferation in Wnt1Cre2SOR Yap; Taz dCKO embryos, which did 
display neural tube closure defects (Fig. 2R). However, no obvious difference was detected in 
cell proliferation within the neural tube between Wnt1Cre2SOR Yap; Taz dCKO and control 
embryos (Fig. S4). Moreover, when we performed immunofluorescence studies to evaluate 
the expression of the actin-severing protein cofilin 1 (CFL1), an important factor for neural 
tube closure, we found no obvious difference between Wnt1Cre2SOR Yap; Taz dCKO and 
control embryos (Fig. S5). 
Our RNA-Seq data indicated that the expression levels of negative regulators of 
apoptosis were lower in Wnt1Cre; Yap; Taz dCKO embryos than in control embryos (Fig. 5C). 
To evaluate cell apoptosis in vivo, we performed terminal deoxynucleotidyl transferase 
(dUTP) nick end labeling (TUNEL) analysis in both E9.5 Wnt1Cre; Yap; Taz dCKO mutant 
embryos and control embryos. Our TUNEL data indicated that cell apoptosis was 
significantly increased in E9.5 Wnt1Cre;Yap; Taz dCKO embryos compared to control 
embryos (Fig. 6O-S). 
 
Yap and Taz promote smooth muscle differentiation 
Our RNA-Seq data indicated that genes involved in vasculogenesis are downregulated in 
Wnt1Cre; Yap; Taz dCKO embryos when compared with control embryos (Fig. 5C). 
Moreover, Lightsheet microscopy revealed severe vessel defects in Wnt1Cre; Yap; Taz dCKO 
embryos than in control embryos (Fig. 4). A recent study indicated that Yap and Taz 
deficiency gives rise to smooth muscle differentiation defects partially derived from the CNC 
(Manderfield et al., 2015) . Given the similar vessel defects in Wnt1Cre; Yapf/f; Tazf/+ embryos 
and Wnt1Cre; Yap; Taz dCKO embryos, we hypothesized that Yap alone plays a critical role in 
the regulation of smooth muscle differentiation. Accordingly, we created a Yap null O9-1 cell 
line (Yap KO O9-1) by removing exon 3 of Yap using CRISPR/Cas9-mediated genome 
editing (the strategy is shown in Fig. 7A and details are provided in the Methods section). 
Compared to wild-type O9-1 cells, Yap KO O9-1 cells had diminished SMA protein 
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expression and Yap activity (Fig. 7B). SMA immunofluorescence indicated that under 
differentiation conditions (see Methods section), wild-type O9-1 cells gave rise to SMA-
positive smooth muscle cells, but the ability of Yap KO O9-1 cells to generate SMA-positive 
cells was significantly diminished supporting the idea that Yap plays the predominant 
function is SMC differentiation perhaps because it is more highly expressed in CNC (Fig. 
7C-E). 
 
Hydrocephalus in Yapf/+; Tazf/f CKO embryos 
Although Wnt1Cre; Yapf/+; Tazf/f and Wnt1Cre2SOR; Yapf/+; Tazf/f embryos did not show any 
obvious defects before E10.5 (Fig. 2; Fig. S1), they developed hydrocephalus at later stages 
(Fig. S6E-G; Fig. S7D-F). Hydrocephalus is mainly characterized by the abnormal widening 
of brain spaces caused by the excessive accumulation of cerebrospinal fluid, which places 
harmful pressure on the surrounding tissues of the brain.  Figure S6E-G shows a 
representative example of an E12.5 Wnt1Cre; Yapf/+; Tazf/f embryo that had severe 
hydrocephalus in the hindbrain. In addition, in the sagittal sections of control embryos (Fig. 
S6D,d), the cerebellum structure is clearly visible, whereas it is missing in the Wnt1Cre; 
Yapf/+; Tazf/f embryos (Fig. S6H,h). The hydrocephalus phenotype was detected as early as 
E11 in Wnt1Cre; Yapf/+; Tazf/f embryos, but it was not observed in either Wnt1Cre; Yapf/f; Tazf/+ 
or Wnt1Cre; Yap; Taz dCKO embryos, most likely because of their lethality at E10.5. 
Moreover, Wnt1Cre; Yapf/f embryos at E11 also had severe hydrocephalus (Fig. S8M-P) when 
compared to controls (Fig. S8I-L). Wnt1Cre2SOR; Yapf/+; Tazf/f embryos at E12.5 presented 
more severe hydrocephalus (Fig. S7D-F) than that in Wnt1Cre; Yapf/+; Tazf/f embryos in the 
hindbrain region and forebrain region. Notably, our RNA-Seq data (Fig. 5) suggested that 
genes required for forebrain and hindbrain morphogenesis were regulated by Taz and Yap, 
such as Foxc1. Foxc1 loss of function also leads to hydrocephalus in mice (Kume et al., 
1998). 
 
Yap and Taz regulate Fox genes 
Our RNA-Seq data indicated that Yap and Taz modulated the expression of multiple members 
of the winged-helix/forkhead box (Fox) transcription factor family, including the 
upregulation of Foxe1, Foxh1, Foxj1, and Foxo3, as well as the downregulation of Foxc1 
(Fig. 5D). We focused on Foxc1 in part because its expression was reduced in Wnt1Cre; Yap; 
Taz dCKO embryos and Yap and Taz are thought to be transcriptional activators. Indeed Yap 
ChIP Seq data showed that genome wide Yap peaks are enriched in active chromatin regions 
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as defined by H3K27Ac chromatin marks (Morikawa et al., 2015). We reasoned that 
downregulated genes were more likely to be direct Yap/Taz target genes. Moreover, Foxc1 is 
the gene mutated in the congenital hydrocephalus mouse mutant (Kume et al., 1998).  
Immunohistochemistry data indicated that Foxc1 is normally expressed in the 
majority of the epithelial and mesenchymal cells in the mandible (sagittal view in Fig. 8A-b2; 
coronal view in Fig. S9A-b2), yet Foxc1 expression was missing or reduced in the majority 
of mesenchymal cells and unchanged in the mandibular epithelial cells in Wnt1Cre; Yap; Taz 
dCKO embryos (sagittal view in Fig. 8C-d2; coronal view in Fig. S9C-d2). On the basis of 
cell counting, the number of Foxc1-positive cells was significantly lower in the Wnt1Cre; Yap; 
Taz dCKO mandible than in the control mandible (p<0.01, Fig. 8E). Furthermore, Foxc1 
immunofluorescence staining indicated that Foxc1 expression was significantly lower in Yap 
knockout; Taz knockdown O9-1 cells (Fig. 8G) than in wild-type O9-1 cells (Fig. 8F) 
(p<0.05, Fig. 8H). Western blot analysis of Foxc1 further indicated that Foxc1 expression 
was decreased in response to the decrease in Yap and Taz expression levels (Fig. 8I).  
Importantly, we identified a conserved binding site for Tead, the Yap and Taz 
cofactor, in Foxc1 (Fig. 8J). Craniofacial cis-regulatory landscapes were recently studied by 
deep-sequencing of transposase-accessible chromatin (ATAC-seq) in human and chimpanzee 
cranial neural crest cells (Prescott et al., 2015). Bioinformatic analysis of these data set 
(accession no. GSE70751) revealed increased chromatin accessibility in a region located 
upstream of the 5’ UTR of FOXC1. Significantly, this putative enhancer region contained a 
potential TEAD DNA-binding element (Fig. 8J). The TEAD binding element was confirmed 
by chromatin immunoprecipitation (ChIP) PCR in murine embryonic facial tissue using an 
anti-Yap antibody, indicating that a Yap-Tead complex directly binds to Foxc1 chromatin 
during embryonic facial morphogenesis (Fig. 8K). 
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DISCUSSION 
During normal development, regeneration, and cancer progression, Hippo signaling inhibits 
proliferation while promoting apoptosis. Here, we show that, during craniofacial 
development, Yap and Taz, the final downstream effectors of Hippo signaling, regulate 
multiple events in CNC diversification including vasculogenesis, smooth muscle 
differentiation, cerebellar development, and neural tube closure. Furthermore, our data 
indicate that Foxc1 is an important downstream target of Yap and Taz. Significantly, Foxc1 
loss of function in mouse embryos phenocopies several of the morphological defects present 
in Yap and Taz mutant embryos. 
 
Overlapping functions for Yap and Taz during craniofacial development 
Using either a Wnt1Cre or Wnt1Cre2SOR driver, Yap and Taz conditional CNC mutants presented 
with disrupted craniofacial vascular development and hemorrhage. We also observed 
hydrocephalus in Yapf/+; Tazf/f mutants established by using both Cre drivers, at later 
embryonic stages. It is most likely that Yap and Taz have redundant functions when they are 
co-expressed, but at earlier developmental stages, Taz expression is lower than that of Yap. 
Interestingly, we did observe a phenotypic difference in embryos when we deleted Yap and 
Taz using the two Cre drivers. Deleting Yap and Taz with the Wnt1Cre2SOR driver resulted in 
anterior neural tube closure defects at E10.5, whereas Wnt1Cre; Yapf/f; Tazf/+ and Wnt1Cre; Yap; 
Taz dCKO embryos showed no neural tube closure defects. Wnt1Cre directs ectopic Wnt1 
activity in the midbrain, whereas Wnt1Cre2SOR has normal Wnt1 activity in the midbrain 
(Lewis et al., 2013). Because Wnt signaling is known to stabilize Yap and Taz (Azzolin et al., 
2014), our data suggest that the phenotypic differences observed between mutants obtained 
by using Wnt1Cre and Wnt1Cre2SOR may be caused by elevated Wnt signaling from the Wnt1Cre 
transgene (Chai et al., 2000). 
 
Yap and Taz regulate vascular development 
The diminished expression of CD31 in E10.5 Yap and Taz mutants indicated that Yap and Taz 
have an essential role in craniofacial vascular development. We found that the multipotent 
O9-1 NC cells treated with siRNAs targeting Yap and Taz were defective in their ability to 
differentiate into smooth muscle cells. Moreover, our RNA-Seq data revealed that genes 
functioning in adherens junction formation, endothelial cell migration, vasoconstriction, and 
the cytoskeleton were differentially expressed in Yap and Taz mutants, suggesting that other 
developmental events may also contribute to defective vascular development. 
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We noted that genes encoding the Jak-Stat cascade components, including Jak3, 
Ptk2b, Stat3, Stat5a, and Stat5b, were upregulated in Wnt1Cre; Yap; Taz dCKO mutants. A 
previous study reported that the activation of Stat3 promotes the apoptosis of vascular smooth 
muscle cells by triggering mitochondria mediated cell death receptors and cell death 
pathways (Bai et al., 2008). Further work is required to investigate the role of increased Jak-
Stat pathway components during craniofacial development in an in vivo setting.  
Prox1, a regulator of lymphatic development, transcripts were also elevated in Yap 
and Taz mutant embryos. Specification of lymphatic endothelial cells is an essential event in 
vascular development (Wigle and Oliver, 1999; Wigle et al., 2002; Johnson et al., 2008); 
thus, elevated Prox1 levels may conceivably disrupt normal vascular specification. It will be 
interesting to determine in future experiments whether increased Prox1 expression leads to 
fate switching to a predominantly lymphatic endothelial cell phenotype. 
We found that Pdgfb is also upregulated in Yap and Taz mutant embryos. PDGF 
signaling has been implicated both directly and indirectly in the regulation of vasculogenesis 
and angiogenesis. Given the critical role of Pdgfb in regulating the recruitment and 
proliferation of vascular cells (Yancopoulos et al., 2000), the defective vascular development 
observed in Yap and Taz mutant embryos may be related to increased Pdgfb expression. 
 
The Hippo pathway regulates CNC proliferation and apoptosis 
We showed that proliferation was significantly reduced in the mandibular mesenchyme in 
Yap and Taz mutant embryos. This diminished proliferation is consistent with our observation 
of reduced cell density surrounding the enlarged vessels in Yap and Taz mutant embryos. 
Furthermore, a recent study showed that NC migration and fate specification were spared in 
Wnt1Cre; Yap; Taz embryos at E10.5, suggesting that Yap and Taz regulate proliferation in the 
post migratory CNC (Manderfield et al., 2014). In Wnt1cre2SOR; Yap; Taz embryos, we also 
found that proliferation was intact in the neural tube, despite the open neural tube phenotype, 
indicating that other mechanisms likely account for the failure of neural tube closure. 
Consistent with our in vivo observations, we found that the siRNA-mediated 
knockdown of Yap and Taz significantly reduced the proliferation of multipotent NC O9-1 
cells, further supporting that Yap and Taz are critical for NC cell proliferation. We also 
showed that the knockdown of Lats1 and Lats2 significantly increased the proliferation of 
O9-1 cells, which is consistent with the idea that Yap and Taz function as Hippo pathway 
effectors to regulate NC proliferation. 
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In addition, apoptosis was significantly increased in the mandibular mesenchyme in 
Yap and Taz mutant embryos. Both decreased proliferation and increased apoptosis were 
observed in E9.5 Yap and Taz mutant embryos in the absence of any detectable hemorrhage, 
indicating that the reduced cell proliferation and sparse cell density observed in E10.5 Yap 
and Taz mutant embryos were caused by a direct, primary effect of Yap and Taz, rather than a 
secondary effect due to the hemorrhaging. 
 
The regulation of Fox genes by Yap and Taz and their potential roles in human disease 
Fox transcription factors are key regulators of embryogenesis and control fundamental 
biological processes including cell proliferation, fate determination, differentiation, and 
growth (Kaufmann and Knochel, 1996; Kume et al., 1998; Kidson et al., 1999; Kume et al., 
2001; Tuteja and Kaestner, 2007b; Tuteja and Kaestner, 2007a; Benayoun et al., 2011; 
Haldipur et al., 2014). Notably, Fox genes are evolutionarily and functionally conserved 
across multiple species, including mice and humans, making animal models invaluable tools 
for understanding the mechanisms underlying human diseases caused by Fox genes. 
Expression of Foxc1 was downregulated at the mRNA and protein level in Yap and 
Taz mutant embryos. Foxc1 has been implicated in several different human disorders 
including the most common cerebellar malformation, Dandy-Walker malformation (DWM); 
Axenfeld-Rieger syndrome (ARS); 6p25 deletion syndrome; and iridogoniodysgenesis 
(Mears et al., 1998; Nishimura et al., 1998; Maclean et al., 2005; Aldinger et al., 2009; 
Delahaye et al., 2012). In addition to the function of Foxc1 in different diseases, it also has 
critical roles in the development of multiple organs and tissues including cerebellar, skull, 
ocular, and cardiovascular development (Kume, 2009). Notably, compound Foxc1 and Foxc2 
knockout mouse embryo mutants have craniofacial abnormalities similar to those of Yap; Taz 
mutants, such as enlarged blood vessels, sparse mesenchyme, and an open neural tube (Kume 
et al., 2001). 
Patients with mutations in Foxc1 display a variant of the Dandy Walker 
malformation, including cerebellar vermis hypoplasia (CVH). Notably, Foxc1 mutant mice 
also have an enlarged fourth ventricle roof plate. Similar to Foxc1 mutant mice, Yap; Taz 
dCKO mice also display cerebellar hypoplasia with an enlarged fourth ventricle roof plate.  
In addition, Foxc1 knockout mice are reported to have hydrocephalus (Kume et al., 1998), a 
severe and common lethal human birth defect, that was also observed in mice with Yap 
inactivation and Taz heterozygosity in NC cells. Collectively, these findings further support 
the hypothesis that Foxc1 is a downstream effector of Yap and Taz. 
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MATERIALS AND METHODS 
Mouse alleles and transgenic lines 
All animal experiments in this study were approved by the Baylor College of Medicine 
Institutional Review Board. The Wnt1Cre, Wnt1Cre2SOR, Yapflox/+ and Tazflox/+ mouse lines and 
alleles used in this study have been described previously (Chai et al., 2000; Xin et al., 2011; 
Lewis et al., 2013; Xin et al., 2013).  
 
Histology and hematoxylin and eosin (H&E) staining 
All embryos were dissected in phosphate-buffered saline (PBS) and fixed in 4% 
paraformaldehyde (PFA) overnight at 4°C. For H&E staining, the fixed embryos were 
dehydrated with an ethanol series (70% to 100%) and xylene and then embedded in paraffin. 
These tissues were subsequently cut into 7-μm sections and stained with H&E, as previously 
described (Lu et al., 1999). 
 
O9-1 cell culture and siRNA knockdown 
The O9-1 cells were cultured under undifferentiating conditions by following a previously 
published protocol (Ladher et al., 2000). The culture medium used consisted of Dulbecco's 
Modified Eagle’s Medium supplemented with 15% fetal bovine serum, 0.1 mM MEM 
Nonessential Amino Acids, 1 mM sodium pyruvate, 55 µM β-mercaptoethanol, 100 units/mL 
penicillin/streptomycin, and 2 mM L-glutamine. Importantly, the medium was conditioned 
with growth-inhibited STO (Mouse embryonic fibroblast cell line) feeder cells overnight, 
filtered (0.22 µm pore size), and further supplemented with 25 ng/mL basic fibroblast growth 
factor (R&D Systems, Minneapolis, MN, 233-FB) and 1000 U leukemia inhibitory factor 
(EMD Millipore, Danvers, MA, ESG1106). The conditions used for smooth muscle 
differentiation were described previously (Ishii et al., 2012). For the siRNA knockdown 
experiments in O9-1 cells, siRNA SMARTpools targeting Yap, Taz, and Hippo kinases Lats1 
and Lats2 were purchased from Dharmacon, Inc. (Lafayette, CO), and the transfections were 
performed by following a typical RNAiMAX transfection procedure (Thermo Fisher 
Scientific, Waltham, MA). 
 
Yap exon 3 deletion by using CRISPR/Cas9 
To make a Yap null O9-1 cell line, exon 3 of Yap was deleted using CRISPR/Cas9 genome 
editing. Two sgRNAs flanking exon 3 were identified using the sgRNA design tool 
(http://www.dna20.com). Four sgRNA oligonucleotides with overhanging BbsI restriction 
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sites were synthesized by IDT (Coralville, IA): 5'-CACCGtggattacgtgggtatgtt-3' (sgRNA1-
forward), 5'-AAACaacatacccacgtaatccac-3' (sgRNA1-reverse), 5'-
CACCGagatggtctaatgtagtga-3' (sgRNA2-forward), and 5'-AAACtcactacattagaccatctC-3' 
(sgRNA2-reverse). The paired oligonucleotides were annealed and ligated into a 
pSpCas9(bb)-2a-GFP vector (Addgene, Cambridge, MA, plasmid #48138). To create cell 
lines with a deletion of Yap exon 3, we transfected pSpCas9-GFP-YAP-sgRNA1 and 
pSpCas9-GFP-YAP-sgRNA2 into O9-1 cells using Lipofectamine 2000 (Thermo Fisher 
Scientific). Twenty-four hours after the transfection, the cells underwent fluorescence-
activated cell sorting (FACS) with GFP/7-AAD. Viable, single cells (7-AAD-;GFP+)  were 
seeded into 96-well plates with culture medium. After 4-5 days, single colonies could be 
observed in some of the wells; wells that had more than one colony were excluded from 
further analyses. The single colonies were passaged into 12-well plates and incubated for 2-4 
days to expand the clones. When the cells were more than 80% confluent, they were 
dissociated with trypsin and half of the sample was processed for DNA extraction while the 
other half was used to make a freezer stock culture. To detect the Yap exon 3 deletion, we 
designed PCR primers flanking the sgRNA recognition sites: 5’-
AAAACAGTCTCCACTACCCCTT -3’ (forward) and 5’-
GGCCATCATAGATCCTGGACG-3’ (reverse). Clones harboring a homozygous deletion 
for Yap exon 3 were retained and used for experimental analyses. 
 
3D embryo imaging with optical projection tomography (OPT) microscopy 
Optical projection tomography microscopy was used to determine embryonic craniofacial 
morphology. Specimens were embedded in 1% agarose (AMRESCO LLC, Solon, OH) and 
dehydrated in 25%, 50%, 75%, and 100% ethanol (Sigma-Aldrich, St. Louis, MO) for 2 
hours each. Samples were then stored in fresh 100% ethanol overnight before clearing. The 
dehydrated samples were then completely cleared in BABB solution, which contained one 
part benzyl alcohol (Thermo Fisher Scientifics) and 2 parts benzyl benzoate (Acros Organics, 
Waltham, MA). Samples were then imaged on a home-build OPT system (BCM-OPT) (Singh 
et. al submitted) modified from a previous version (Wong et al., 2013). The BCM-OPT 
microscope consisted of an Optem Zoom 125C lens (Qioptiq, Waltham, MA) and an 
auxiliary objective lens attached to a Retiga 4000DC FAST 1394 CCD camera (QImaging, 
Surrey, BC) with a 1.38x TV tube (Qioptiq). Autofluorescence images of the embryos were 
acquired with an X-Cite illumination light source (EXFO, Quebec, QE) and both a 425/26 nm 
BrightLine bandpass excitation filter and a 520/20 nm emission filter (Semrock, Rochester, 
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NY). The embryos were rotated 360 degrees, with each view taken with a 0.3-degree step 
size. Acquired images were reconstructed by using NRecon Reconstruction software, and 3D 
rendering was performed by using CTVox software (Bruker Corporation, Camarillo, CA). 
 
Immunofluorescence and immunohistochemistry 
After the embryos were fixed overnight in 4% PFA and dehydrated, they were embedded in 
paraffin, cut into 7-µm sections, and collected on Superfrost Plus slides (Fisher Scientific, 
Pittsburgh, PA). The sections were rehydrated using xylene and a graded ethanol series to a 
final concentration of 70% and then processed for antigen retrieval.  
For the immunofluorescence analysis, the antigens were retrieved by incubating the 
slides in citrate buffer (10 mM) for 2 minutes in a microwave oven. Nuclei were stained with 
4,6-diamidino-2-phenylindole (DAPI) at a 1:500 dilution. Primary antibodies against 
phospho-histone H3 (Cell Signaling Technology, Inc., Danvers, MA) and FoxC1 (Abcam, 
Cambridge, MA) were used at a 1:200 dilution. A broad HRP-conjugated secondary antibody 
(Invitrogen) was used according to the manufacturer’s guidelines. An anti-SMA-Cy3 
antibody (Sigma-Aldrich, Clone 1A4) was used at a 1:200 dilution. Staining was then 
visualized by using a TSA Plus Fluorescence System (PerkinElmer, Boston, MA) and a Zeiss 
LSM 510 confocal microscope. 
For the immunohistochemistry analysis, the antigens were retrieved by boiling the 
sections in ethylenediaminetetraacetic acid for 15 minutes, and then the tissues were 
permeabilized by incubating the sections with 0.5% triton X-100 for 15 minutes. Afterwards, 
the sections were treated with 0.3% H2O2 for 15 minutes and blocked with 10% donkey 
serum for 1 hour. The sections were incubated with primary antibody against FoxC1 (Novus 
Biologicals, Littleton, CO) at a 1:200 dilution overnight at 4°C. The next day, the sections 
were incubated with HRP-conjugated anti-goat IgG antibody (1:200 dilution) for 1 hour and 
then developed with DAB substrate (Vector Laboratories, Inc., Burlingame, CA) for 2 
minutes and 30 seconds. Sections were subsequently washed with H2O, stained with 
hematoxylin for 3 minutes, and then washed with H2O again for 5 minutes. Then, they were 
dehydrated with an ethanol series to a final concentration of 100% and xylene and mounted. 
 
Whole mount immunohistochemistry 
E10.5 embryos were processed as described (Wythe et al., 2013). Briefly, the embryos were 
fixed in 4% PFA overnight, serially dehydrated to absolute methanol, bleached in 5% H2O2 / 
95% methanol overnight, and rehydrated to PBS-Tween (0.1%). The embryos were blocked 
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for 2 hours (PBS / 5% goat serum / 0.5% Triton X-100), then incubated with an anti-CD31 
antibody (MEC13.3, BD Biosciences, San Jose, CA, 1:200 dilution) in blocking solution for 
3 days. The embryos were then washed and incubated with biotin-conjugated goat anti-rat 
IgG secondary antibody (Vector Laboratories, Inc., 1:250 dilution) for 2 days. The signal was 
amplified with Alexa Fluor 488 Tyramide (Thermo Fisher Scientific, T20948). The embryos 
were then washed in blocking solution and incubated with anti-SMA-Cy3 antibody (Sigma-
Aldrich, Clone 1A4, 1:200 dilution) for 3 days at 4°C. After washing, the embryos were 
cleared in ScaleA2 (Hama H et al., 2011, Nature Neuroscience) for 2 days, ScaleB4 for 2 
days, then embedded in 1% agarose in ddH2O, and cleared for another 2 days in ScaleA2. 
The embryos were then imaged on a Lightsheet Z.1 (Zeiss) using a 5X air lens (NA=0.16) in 
ScaleA2. All images were obtained using the same laser power and exposure time. Serial 
images were aligned using Zen software (Zeiss, Irvine, CA), and 3D rendering was 
performed with Imaris software (Bitplane USA, Concord, MA). 
 
RNA-Seq and data analysis 
Mandibular tissues from Wnt1cre, Yap, and Taz dCKO mutant and control E10.5 embryos 
were dissected in diethylpyrocarbonate-treated PBS. Total RNA extracted from these tissues 
was treated with RNAse free DNase I (Ambion) for 30 min at 37°C. Then, the poly(A) RNA 
was purified with the MicroPoly(A) Purist Kit according to the manufacturer’s instructions 
(Thermo Fisher Scientific). The purified RNA samples were processed for cDNA synthesis 
and library preparation. cDNA sequencing using the Illumina platform and read mapping 
were performed as previously described (Nagalakshmi et al., 2008). Datasets were processed 
for gene ontology analysis, which provided different terms that represent gene properties 
including cellular components, molecular function, and biological processes. The data were 
deposited in the Gene Expression Omnibus (GEO) database (accession no. GSE69311). More 
information is available at 
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=ejajwkiynvevjuj&acc=GSE69311. 
 
Chromatin immunoprecipitation (ChIP) 
Embryonic orofacial tissues from wild type mice at stages E10.5-E11.5 were dissected for 
Yap ChIP analysis, as previously described (Wang et al., 2013). Normal rabbit IgG was used 
as a replacement control for the anti-Yap ChIP assay to show nonspecific 
immunoprecipitation of the chromatin. The primers used to amplify the TEAD regulatory 
element in the 5′ upstream region of the Foxc1 genomic sequence were 5′- 
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CCTTGGCATCTCTCAGAAAGTC -3′ (sense) and 5′- TAGTCCTATCCCAGTGAGCATC 
-3′ (antisense). 
 
Real-time PCR 
For the real-time RT-PCR analysis, total RNA was isolated from the mandibles of E10.5 
embryos or O9-1 cells by using the RNeasy Micro Kit (Qiagen) and processed for cDNA 
synthesis using Super Script II Reverse Transcriptase (Invitrogen). For the real-time ChIP-
PCR analysis, immunoprecipitated DNA and input DNA were used as templates. All real-
time thermal cycling was performed with the StepOne Real-time PCR System (Thermo 
Fisher Scientific). SYBR Green JumpStart Taq ReadyMix (Sigma-Aldrich) was used for real-
time thermal cycling. All error bars represent SEM. 
 
Cell counts and data analyses 
For embryonic cell counting, all embryos used were at the same embryonic stage. The 
embryos were embedded carefully to maintain the same orientation and were sectioned at 
identical thickness (5 m). Sections were carefully chosen to represent the matching regions 
between control and mutant embryos. Our analyses included at least 3 embryos for each 
genotype. For O9-1 cell counting, each experiment was performed in duplicate and all 
experiments were repeated 3 times or more. Image J software (National Institutes of Health, 
Bethesda, MD) was used to perform the cell counting and over 200 cells was counted for 
each experiment. The percentage of proliferating cells was determined by counting the 
pHH3-positive cells and dividing that number by the number of DAPI-positive cells. The 
percentage of apoptotic cells was determined by counting the number of TUNEL-positive 
cells. All counting data are represented in graphs as the mean ± SEM. The 2-tailed t-test was 
used to determine statistical significance, and P<0.05 was considered statistically significant. 
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Figures 
 
 
 
 
Fig. 1. Efficient deletion of Yap and Taz in CNC-derived cells. Hippo signaling activity, 
indicated by the level of phosphorylated Yap (pYAP), is shown in control embryos (A-B) and 
in Wnt1Cre; Yapf/f  ;Tazf/f embryos (C-D). pYAP levels were reduced in CNC-derived cells 
(white arrows) but not in non-CNC derived cells (red arrows). Hippo-active cells (green) 
were stained with pYAP; nuclei (blue) were stained with DAPI. 
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Fig. 2. Vascular defects, hemorrhage, and neural tube defects following Yap and Taz 
inactivation using the Wnt1Cre2SOR Cre driver. Both Wnt1Cre2SOR; Yap; Taz dCKO (A-D) 
and Wnt1Cre2SOR; Yapf/f; Tazf/+ (M-P) embryos showed lethality at E10.5 with severe vascular 
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defects, hemorrhage, and defects in neural tube closure, whereas control embryos (I-L) and 
Wnt1Cre2SOR; Yapf/+; Tazf/f embryos (E-H) showed no obvious defects. Zoomed-in images of 
branchial arch vessel defects, hemorrhage, and neural tube defects of Wnt1Cre2SOR; Yapf/f; 
Tazf/+ embryos are shown (m-p). Three dimensional imaging using optical projection 
tomography microscopy indicated that the neural tube of control embryos closed normally 
(Q), whereas Wnt1Cre2SOR; Yap; Taz dCKO embryos had a defect in neural tube closure (R). 
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Fig. 3. Histologic analysis showing the disruption of mandibular structure in Yap and 
Taz–deficient embryos. Coronal sections stained with hematoxylin and eosin showing that, 
in contrast to control embryos (A-D), both Wnt1Cre; Yap; Taz dCKO (E-L) and Wnt1Cre; 
Yapf/f; Tazf/+ (M-P) embryos had disorganized, sparse mesenchyme (black arrows) and 
enlarged vessels (red stars) in the mandible. Boxed areas are shown at higher magnification 
in panels to the right, as labeled. 
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Fig. 4. Severe vessel defects caused by Yap and Taz deletion. Whole mount CD31 
immunofluorescence staining in a control (A) and a Wnt1Cre; Yap; Taz dCKO mutant (B) 
revealed vessel defects and endothelial-lined hemangiomas in the forebrain and mandible in 
Wnt1Cre; Yap; Taz dCKO mutants (B). The boxed area in B is shown at a higher 
magnification in C, focusing in on the endothelial-lined hemangiomas in the branchial arch in 
the Yap; Taz dCKO embryo (C). Whereas control embryos had normal vessel development in 
brain (D-F), Wnt1Cre; Yap; Taz dCKO mutants had vessel regression and disorganization 
(different regions are labeled as 1-4). (G-I). Endothelial cells (green) are stained with CD31 
antibody; smooth muscle cells (red) are stained with SMA antibody; and auto fluorescence is 
shown in blue.  
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Fig. 5. The regulation of multiple signals by the Hippo pathway in CNC-derived cells. 
RNA-Seq analysis was performed by using mandibular tissues from E10.5 control embryos 
and Wnt1Cre Taz; Yap dKO mutants. (A) RNA-Seq analysis indicates that Yap and Taz 
expression levels (indicated by reads) were decreased by 40% to 50% in Wnt1Cre Taz; Yap 
dKO embryos compared to control embryos. (B) Gene ontology analysis shows genes that are 
upregulated in Wnt1Cre Taz; Yap dKO embryos compared to control embryos, which includes 
genes that regulate adherens junctions, vasoconstriction, and the cytoskeleton. (C) Gene 
ontology analysis shows genes that are downregulated in Wnt1Cre Taz; Yap dKO embryos 
compared to control embryos, which includes genes that regulate cell proliferation and 
vasculogenesis and that negatively regulate canonical Wnt.  (D) Heat map of RNA-Seq data 
shows that, compared to controls, Wnt1Cre Taz; Yap dKO mutants had downregulated 
expression of Foxc1 and upregulated expression of Foxe1, Prox1 , Pdgfb, and Jak-Stat genes 
including Jak3, Ptk2b, Stat3, Stat5a, and Stat5b. 
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Fig. 6. The regulation of proliferation and apoptosis in CNC cells by the Hippo 
pathway. Compared to control embryos, Wnt1Cre; Yap; Taz dCKO embryos had a 
significantly diminished percentage of pHH3-positive proliferating cells in the mandible at 
E9.5 and E10.5 (A-J). Proliferating cells (green) were stained with pHH3 antibody; smooth 
muscle cells (red) were stained with SMA antibody; and nuclei (blue) were stained with 
DAPI. *p<0.05.  (K-N) Compared to O9-1 cells transfected with control (con) siRNA, O9-1 
cells transfected with Yap and Taz siRNA had significantly reduced proliferation, and O9-1 
cells transfected with Lats1 and Lats2 siRNA had significantly increased proliferation 
(*p<0.05). Proliferating cells (green) were stained with pHH3 antibody; nuclei (red) were 
stained with DAPI.  (O-S) Compared to control embryos, Wnt1Cre; Yap; Taz dCKO embryos 
had a significantly increased percentage of apoptotic cells in the mandible at E9.5 (*p<0.05). 
Apoptotic cells (green) were stained with TUNEL; nuclei (blue) were stained with DAPI. All 
error bars represent SEM.  
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Fig. 7. The requirement of Yap for smooth muscle differentiation. The strategy for 
establishing a Yap knockout (KO) O9-1 cell line by using CRISPR/Cas9 system (A). 
Specifically, exon 3 was deleted from Yap. Western blot data shows diminished SMA and 
pYap expression in Yap KO O9-1 cells compared to wild type (wt) O9-1 cells (B). Under 
differentiation conditions, most wild type O9-1 cells give rise to smooth muscle cells (C), 
whereas Yap KO O9-1 cells did not give rise to smooth muscle cells (D) Arrows designate 
SMA positive cells. Cell counting data show that the percentage of SMA-positive cells was 
significantly reduced in Yap KO O9-1 cells compared to wild type O9-1 cells (*p<0.01). 
Error bars represent SEM. (E). Smooth muscle cells (red) were stained with SMA antibody; 
nuclei (blue) were stained with DAPI. 
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Fig. 8. The regulation of Foxc1 by Yap and Taz. Immunohistochemical staining of Foxc1 
in sagittal sections of the mandible show that the majority of cells in control embryos express 
Foxc1 (A-B, b1-b2), whereas the expression of Foxc1 was diminished in Wnt1Cre; Yap; Taz 
dCKO embryos (C-D, d1-d2). Boxed areas are shown at higher magnification in panels to the 
right, as labeled. Cell counting data show that the percentage of cells positive for Foxc1 
expression in the mandible was significantly reduced in Wnt1Cre; Yap; Taz dCKO embryos 
compared to control embryos (E) (*p<0.01). Immunohistochemical staining of Foxc1 in O9-1 
cells shows significantly decreased Foxc1 expression in Yap knockout (KO); Taz knockdown 
(KD) O9-1 cells compared to wild-type O9-1 cells (*p<0.05) (F-H). Arrows designate Foxc1 
positive cells. Western blot analysis of Foxc1 in O9-1 cells shows decreased Foxc1 
expression in response to decreased Yap and Taz expression level (I). (J) Conserved Tead 
binding site located in the upstream region of FOXC1. Peaks in ATAC-seq data (accession 
no. GSE70751) indicated chromatin accessibility (Prescott et al., 2015). (K) In vivo real-time 
PCR using ChIP DNA indicates that Foxc1 was bound by the Yap-Tead complex in 
embryonic facial tissue. p<0.05. All error bars represent SEM. 
